Quest Diagnostics Q1 2026 Earnings Report Shows Revenue Growth and Margin Improvements
Quest Diagnostics (DGX) reported Q1 2026 revenue of $2.9 billion, up 9.2% year-over-year, driven by organic growth and expanded collaborations. The company raised its 2026 revenue guidance to $11.78 billion–$11.9 billion and saw adjusted diluted EPS increase by 13% to $2.50. Operating income and margins improved due to productivity gains and volume growth.
Tickers: $DGX
Topics: earnings EPS financial performance guidance operating income revenue growth